Skip to main content
رجوع
ABT logo

Abbott Laboratories

جودة البيانات: 100%
ABT
NYSE Healthcare Medical - Devices
KWD 104.85
▼ KWD 0.61 (-0.58%)
القيمة السوقية: 182.20B
نطاق اليوم
KWD 104.10 KWD 107.07
نطاق 52 أسبوعًا
KWD 104.10 KWD 139.06
حجم التداول
5,891,472
متوسط 50 يوم / 200 يوم
KWD 113.11 / KWD 125.68
الإغلاق السابق
KWD 105.46

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E 27.9 0.4
P/B 3.5 2.9
ROE % 13.1 3.7
Net Margin % 14.7 3.9
Rev Growth 5Y % 0.7 10.0
D/E 0.3 0.2

السعر المستهدف للمحللين

Hold
KWD 137.670 +31.3%
Low: KWD 120.000 High: KWD 158.000
مكرر الربحية المستقبلي
18.5
ربحية السهم المستقبلية
KWD 5.675
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
48 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 8.357
KWD 8.218 – KWD 8.707
63 B 4
FY2029 KWD 7.559
KWD 7.433 – KWD 7.876
59 B 4
FY2028 KWD 6.867
KWD 5.927 – KWD 7.453
55 B 11

Insider Trading Activity

Buy ratio (90d) 0.0%
20 transactions
Date Insider Type Shares Price Value
Mar 2, 2026
Shroff Eric
Senior Vice President
sell 709 KWD 115.580 KWD 81,946
Mar 2, 2026
Cushman Elizabeth C.
EVP, GC AND SECRETARY
sell 263 KWD 115.580 KWD 30,398
Mar 2, 2026
Morrone Louis H.
EXECUTIVE VICE PRESIDENT
sell 1,144 KWD 115.580 KWD 132,224
Feb 27, 2026
Shroff Eric
Senior Vice President
other 1,384 KWD 116.260 KWD 160,904
Feb 27, 2026
Boudreau Philip P
EVP AND CFO
other 7,441 KWD 116.260 KWD 865,091
Feb 27, 2026
Ford Robert B
CHAIRMAN AND CEO
other 30,308 KWD 116.260 KWD 3,523,608
Feb 27, 2026
Cushman Elizabeth C.
EVP, GC AND SECRETARY
other 1,421 KWD 116.260 KWD 165,205
Feb 27, 2026
Morrone Louis H.
EXECUTIVE VICE PRESIDENT
other 4,040 KWD 116.260 KWD 469,690
Feb 24, 2026
Ford Robert B
CHAIRMAN AND CEO
grant 427,530
Dec 31, 2025
Stratton John G
grant 313 KWD 125.290 KWD 39,216
Dec 31, 2025
Roman Michael F
grant 301 KWD 125.290 KWD 37,712
Dec 11, 2025
Salvadori Daniel Gesua Sive
EVP AND GROUP PRESIDENT
other 1,536 KWD 123.280 KWD 189,358
Sep 30, 2025
Stratton John G
grant 293 KWD 133.940 KWD 39,244
Jun 30, 2025
Stratton John G
grant 282 KWD 136.010 KWD 38,355
Jun 30, 2025
Morrone Louis H.
EXECUTIVE VICE PRESIDENT
other 269 KWD 134.380 KWD 36,148
Jun 30, 2025
Gonzalez Patricia Paola
grant 242 KWD 136.010 KWD 32,914
Apr 30, 2025
Blount Sally E.
sell 2,600 KWD 129.660 KWD 337,116
Apr 25, 2025
Roman Michael F
grant 1,635
Apr 25, 2025
McDew Darren W
grant 1,635
Mar 31, 2025
Gonzalez Patricia Paola
grant 248 KWD 132.650 KWD 32,897

النقاط الرئيسية

Revenue grew 0.72% annually over 5 years — modest growth
Earnings declined -51.32% over the past year
ROE of 13.07% — decent returns on equity
Debt/Equity of 0.29 — conservative balance sheet
Generating 7.40B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4.95%

النمو

Revenue Growth (5Y)
0.72%
Revenue (1Y)5.67%
Earnings (1Y)-51.32%
FCF Growth (3Y)20.90%

الجودة

Return on Equity
13.07%
ROIC8.98%
Net Margin14.72%
Op. Margin18.16%

الأمان

Debt / Equity
0.29
Current Ratio1.58
Interest Coverage23.60

التقييم

P/E Ratio
27.93
P/B Ratio3.50
EV/EBITDA23.45
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 5.67% Revenue Growth (3Y) 5.13%
Earnings Growth (1Y) -51.32% Earnings Growth (3Y) 6.77%
Revenue Growth (5Y) 0.72% Earnings Growth (5Y) -1.99%
Profitability
Revenue (TTM) 44.33B Net Income (TTM) 6.52B
ROE 13.07% ROA 7.52%
Gross Margin 55.51% Operating Margin 18.16%
Net Margin 14.72% Free Cash Flow (TTM) 7.40B
ROIC 8.98% FCF Growth (3Y) 20.90%
Safety
Debt / Equity 0.29 Current Ratio 1.58
Interest Coverage 23.60 Dividend Yield 0.02%
Valuation
P/E Ratio 27.93 P/B Ratio 3.50
P/S Ratio 4.11 PEG Ratio -0.65
EV/EBITDA 23.45 Dividend Yield 0.02%
Market Cap 182.20B Enterprise Value 188.74B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 44.33B 41.95B 40.11B 43.65B 43.08B
Net Income 6.52B 13.40B 5.72B 6.93B 7.07B
EPS (Diluted) 3.72 7.64 3.27 3.91 3.94
Gross Profit 24.61B 21.33B 20.04B 22.32B 23.21B
Operating Income 8.05B 6.83B 6.44B 8.36B 9.20B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 86.71B 81.41B 73.21B 74.44B 75.20B
Total Liabilities 33.94B 33.51B 34.39B 37.53B 39.17B
Shareholders' Equity 52.13B 47.66B 38.60B 36.69B 35.80B
Total Debt 15.07B 15.28B 15.87B 17.95B 19.25B
Cash & Equivalents 8.52B 7.62B 6.90B 9.88B 9.80B
Current Assets 26.00B 23.66B 22.67B 25.22B 24.24B
Current Liabilities 16.50B 14.16B 13.84B 15.49B 13.11B

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#685 of 1024
37

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026